Neuroactive	neuroactive	O	O
steroids	steroids	S_chemical	O
protect	protect	O	O
against	against	O	O
pilocarpine-	pilocarpine-	O	O
and	and	O	O
kainic	kainic	O	O
acid-induced	acid-induced	O	O
limbic	limbic	O	O
seizures	seizures	O	S_disease
and	and	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
in	in	O	O
mice	mice	O	O
.	.	O	O

Several	several	O	O
structurally	structurally	O	O
related	related	O	O
metabolites	metabolites	O	O
of	of	O	O
progesterone	progesterone	S_chemical	O
(	(	O	O
3	3	O	O
alpha-hydroxy	alpha-hydroxy	O	O
pregnane-20-ones	pregnane-20-ones	O	O
)	)	O	O
and	and	O	O
deoxycorticosterone	deoxycorticosterone	O	O
(	(	O	O
3	3	O	O
alpha-hydroxy	alpha-hydroxy	O	O
pregnane-21-diol-20-ones	pregnane-21-diol-20-ones	O	O
)	)	O	O
and	and	O	O
their	their	O	O
3	3	O	O
beta-epimers	beta-epimers	O	O
were	were	O	O
evaluated	evaluated	O	O
for	for	O	O
protective	protective	O	O
activity	activity	O	O
against	against	O	O
pilocarpine-	pilocarpine-	O	O
,	,	O	O
kainic	kainic	O	O
acid-	acid-	O	O
and	and	O	O
N-methyl-D-aspartate	n-methyl-d-aspartate	O	O
(NMDA)-induced	(nmda)-induced	O	O
seizures	seizures	O	S_disease
in	in	O	O
mice	mice	O	O
.	.	O	O

Steroids	steroids	S_chemical	O
with	with	O	O
the	the	O	O
3-hydroxy	3-hydroxy	O	O
group	group	O	O
in	in	O	O
the	the	O	O
alpha-position	alpha-position	O	O
and	and	O	O
5-H	5-h	O	O
in	in	O	O
the	the	O	O
alpha-	alpha-	O	O
or	or	O	O
beta-configurations	beta-configurations	O	O
were	were	O	O
highly	highly	O	O
effective	effective	O	O
in	in	O	O
protecting	protecting	O	O
against	against	O	O
pilocarpine	pilocarpine	S_chemical	O
(	(	O	O
416	416	O	O
mg/kg	mg/kg	O	O
,	,	O	O
s.c.)-induced	s.c.)-induced	O	O
limbic	limbic	O	O
motor	motor	O	O
seizures	seizures	O	S_disease
and	and	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
(	(	O	O
ED50	ed50	O	O
values	values	O	O
,	,	O	O
7.0	7.0	O	O
-	-	O	O
18.7	18.7	O	O
mg/kg	mg/kg	O	O
,	,	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
.	.	O	O

The	the	O	O
corresponding	corresponding	O	O
epimers	epimers	O	O
with	with	O	O
the	the	O	O
3-hydroxy	3-hydroxy	O	O
group	group	O	O
in	in	O	O
the	the	O	O
beta-position	beta-position	O	O
were	were	O	O
also	also	O	O
effective	effective	O	O
but	but	O	O
less	less	O	O
potent	potent	O	O
(	(	O	O
ED50	ed50	O	O
values	values	O	O
,	,	O	O
33.8	33.8	O	O
-	-	O	O
63.5	63.5	O	O
,	,	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
.	.	O	O

Although	although	O	O
the	the	O	O
neuroactive	neuroactive	O	O
steroids	steroids	S_chemical	O
were	were	O	O
considerably	considerably	O	O
less	less	O	O
potent	potent	O	O
than	than	O	O
the	the	O	O
benzodiazepine	benzodiazepine	S_chemical	O
clonazepam	clonazepam	O	O
in	in	O	O
protecting	protecting	O	O
against	against	O	O
pilocarpine	pilocarpine	S_chemical	O
seizures	seizures	O	S_disease
,	,	O	O
steroids	steroids	S_chemical	O
with	with	O	O
the	the	O	O
5	5	O	O
alpha,3	alpha,3	O	O
alpha-configuration	alpha-configuration	O	O
had	had	O	O
comparable	comparable	O	O
or	or	O	O
higher	higher	O	O
protective	protective	O	O
index	index	O	O
values	values	O	O
(	(	O	O
TD50	td50	O	O
for	for	O	O
motor	motor	O	O
impairment	impairment	O	O
divided	divided	O	O
by	by	O	O
ED50	ed50	O	O
for	for	O	O
seizure	seizure	O	S_disease
protection	protection	O	O
)	)	O	O
than	than	O	O
clonazepam	clonazepam	O	O
,	,	O	O
indicating	indicating	O	O
that	that	O	O
some	some	O	O
neuroactive	neuroactive	O	O
steroids	steroids	S_chemical	O
may	may	O	O
have	have	O	O
lower	lower	O	O
relative	relative	O	O
toxicity	toxicity	O	S_disease
.	.	O	O

Steroids	steroids	S_chemical	O
with	with	O	O
the	the	O	O
5	5	O	O
alpha,3	alpha,3	O	O
alpha-	alpha-	O	O
or	or	O	O
5	5	O	O
beta,3	beta,3	O	O
alpha-configurations	alpha-configurations	O	O
also	also	O	O
produced	produced	O	O
a	a	O	O
dose-dependent	dose-dependent	O	O
delay	delay	O	O
in	in	O	O
the	the	O	O
onset	onset	O	O
of	of	O	O
limbic	limbic	O	O
seizures	seizures	O	S_disease
induced	induced	O	O
by	by	O	O
kainic	kainic	B_chemical	O
acid	acid	I_chemical	O
(	(	O	O
32	32	O	O
mg/kg	mg/kg	O	O
,	,	O	O
s.c	s.c	O	O
.	.	O	O
)	)	O	O
,	,	O	O
but	but	O	O
did	did	O	O
not	not	O	O
completely	completely	O	O
protect	protect	O	O
against	against	O	O
the	the	O	O
seizures	seizures	O	S_disease
.	.	O	O

However	however	O	O
,	,	O	O
when	when	O	O
a	a	O	O
second	second	O	O
dose	dose	O	O
of	of	O	O
the	the	O	O
steroid	steroid	S_chemical	O
was	was	O	O
administered	administered	O	O
1	1	O	O
hr	hr	O	O
after	after	O	O
the	the	O	O
first	first	O	O
dose	dose	O	O
,	,	O	O
complete	complete	O	O
protection	protection	O	O
from	from	O	O
the	the	O	O
kainic	kainic	O	O
acid-induced	acid-induced	O	O
limbic	limbic	O	O
seizures	seizures	O	S_disease
and	and	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
was	was	O	O
obtained	obtained	O	O
.	.	O	O

The	the	O	O
steroids	steroids	S_chemical	O
also	also	O	O
caused	caused	O	O
a	a	O	O
dose-dependent	dose-dependent	O	O
delay	delay	O	O
in	in	O	O
NMDA	nmda	S_chemical	O
(	(	O	O
257	257	O	O
mg/kg	mg/kg	O	O
,	,	O	O
s.c.)-induced	s.c.)-induced	O	O
lethality	lethality	O	O
,	,	O	O
but	but	O	O
did	did	O	O
not	not	O	O
completely	completely	O	O
protect	protect	O	O
against	against	O	O
NMDA	nmda	S_chemical	O
seizures	seizures	O	S_disease
or	or	O	O
lethality	lethality	O	O
.	.	O	O

We	we	O	O
conclude	conclude	O	O
that	that	O	O
neuroactive	neuroactive	O	O
steroids	steroids	S_chemical	O
are	are	O	O
highly	highly	O	O
effective	effective	O	O
in	in	O	O
protecting	protecting	O	O
against	against	O	O
pilocarpine-	pilocarpine-	O	O
and	and	O	O
kainic	kainic	O	O
acid-induced	acid-induced	O	O
seizures	seizures	O	S_disease
and	and	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
in	in	O	O
mice	mice	O	O
,	,	O	O
and	and	O	O
may	may	O	O
be	be	O	O
of	of	O	O
utility	utility	O	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
some	some	O	O
forms	forms	O	O
of	of	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
in	in	O	O
humans	humans	O	O
.	.	O	O

